Debevoise & Plimpton LLP Healthcare Group partners Maura Kathleen Monaghan and Paul D. Rubin have been selected to serve as faculty at the 2017 Vanguard Forum for Healthcare Leaders.
Debevoise partner Paul D. Rubin will discuss critical trends in healthcare and partner Maura Kathleen Monaghan will lead a session about succeeding as an executive in today’s active board environment.
The Vanguard Forum for Healthcare Leaders, presented by The Vanguard Group for Leadership, seeks to engage senior leadership across the healthcare and biopharmaceutical ecosystem with top tier CEOs, advisors and other experts who help define and build leadership for the future. The organization brings together a network to share best practices, approaches and perspectives regarding leadership opportunities and challenges across the industry.
In addition to Debevoise’s Ms. Monaghan and Mr. Rubin, other faculty members at the Forum will include David Pyott (Philips board, former Chairman and CEO, Allergan); Ashley McEvoy, (Group Chairman, J&J); Jeremy Levin, (CEO, Ovid Therapeutics, former CEO, Teva); Tom Sabatino (EVP and GC, Aetna); Peter Hecht (CEO, Ironwood); and Ram Charan (CEO and Board advisor, and best-selling author).
Debevoise’s strategic partnership with The Vanguard Group for Leadership underscores the firm’s commitment to help healthcare businesses prepare and adapt to ongoing changes in today’s market. To help healthcare leaders stay current in this dynamic environment, Debevoise will contribute to Vanguard’s learning curriculum throughout 2018. Additionally, during January’s JP Morgan Healthcare Conference in San Francisco, Debevoise is planning an event that will explore the challenges facing healthcare leaders in the coming decade.
Debevoise’s Healthcare Group handles significant transactions and regulatory and litigation matters for pharmaceutical, life sciences and medical device companies, hospitals, financial sponsors, financial advisors and other key players in the industry. The Group’s transactional work includes mergers and acquisitions, financings, securities offerings, licensing, development and commercialization transactions. The Group’s litigation work spans investigations by U.S. government agencies; a broad range of civil litigation, including state and federal qui tam actions and class action litigation; compliance with U.S. regulatory requirements; advising boards of directors; and the defense of intellectual property rights.
Debevoise & Plimpton LLP is a premier law firm with market-leading practices, a global perspective and strong New York roots. We deliver effective solutions to our clients’ most important legal challenges, applying clear commercial judgment and a distinctively collaborative approach.
See the full release here.